Rowswell-Turner, R. B., Rutishauser, J. A., Kim, K. K., Khazan, N., Sivagnanalingam, U., Jones, A. M., . . . Moore, R. G. (2019). Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer. Transl Oncol.
استشهاد بنمط شيكاغوRowswell-Turner, Rachael B., Jennifer A. Rutishauser, Kyu Kwang Kim, Negar Khazan, Umayal Sivagnanalingam, Aaron M. Jones, Rakesh K. Singh, و Richard G. Moore. "Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer." Transl Oncol 2019.
MLA استشهادRowswell-Turner, Rachael B., et al. "Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer." Transl Oncol 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.